Mesothelioma Information
Gendicine works by combining the gene p53, a tumor inhibitor, with a profit of virus. When the virus is injected into the tumor Gendicine cancer, the virus inserts the gene p53 in cancer cells. Once the p53 gene in cancer cells, causing their destruction. Clinical trials have shown a success rate of 64% in therapy combined with radiotherapy.
Dr. Li is a man Dinggang responsible for the success of this new therapy. He is an oncologist who has spent five years studying in Johns Hopkins University during the 1990s. Since 1997, he collaborated with Dr. Peng Zhaohui, chairman and CEO of pharmaceutical company in China, SiBiono, develop Gendicine. At the age of 50, Dr. Dinggang is the director of the Center for Gene Therapy in China and is actively working on patients with cancer of Haida Hospital in Beijing.
Dr. Dinggang calls for any cancer patient who are interested to submit their treatment Gendicine medical case histories in English and must translated into Chinese. After reviewing the history of China, will respond back with an assessment about whether you should file a petition for admission to hospital for Haida treatment.
It is advisable to seek a friend or someone you know who is fluent Chinese, to seek help for admission to the hospital and basically communicate the administration personnel. In addition, a translator China would help in the organization of transport and local needs for temporary accommodation pending in Beijing.
To obtain information, on how a lawyer can help you pay for the costs of Gendicine, on how to contact Dr. Dinggang and to learn more about Gendicine, visit: New Treatment Mesothelioma. There you will also find information on Mesothelioma Treatments, stories of hope, and the latest news.
